Abstract Although blacks have higher plasma levels of lipoprotein(a) [Lp( a )] than whites, the Lp(a) levels are not associated with clinical coronary artery disease (CAD) or parental history of myocardial infarction in blacks. To explore whether ethnic differences in the pathogenicity of Lp(a) are related to the thrombogenic component of Lp(a), this study investigated in children the associations of apolipoprotein(a) [apo(a)] phenotypes and Lp(a) levels with family history of premature CAD. Subjects were 46 children aged 7 to 11 years divided according to family history of premature CAD and assessed for Lp(a), apo(a) phenotypes, and other lipids and lipoproteins. The prevalence of small isofonns was higher in children with positive family history of premature CAD than in children with negative family history of premature CAD
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Abstract Although blacks have higher plasma levels of lipoprotein(a) [Lp( a )] than whites, the Lp(a) levels are not associated with clinical coronary artery disease (CAD) or parental history of myocardial infarction in blacks. To explore whether ethnic differences in the pathogenicity of Lp(a) are related to the thrombogenic component of Lp(a), this study investigated in children the associations of apolipoprotein(a) [apo(a)] phenotypes and Lp(a) levels with family history of premature CAD. Subjects were 46 children aged 7 to 11 years divided according to family history of premature CAD and assessed for Lp(a), apo(a) phenotypes, and other lipids and lipoproteins. The prevalence of small isofonns was higher in children with positive family history of premature CAD than in children with negative family history of premature CAD N umerous case-control and cross-sectional studies have indicated a moderate to strong association of lipoprotein(a) [Lp(a)] levels with premature coronary artery disease (CAD), 16 restenosis of previously dilated coronary arterial segments, 7 preclinical atherosclerosis, 8 and parental histories of myocardial infarction (MI), 9 -10 particularly among whites. Despite higher levels of Lp(a) in blacks compared with whites, the Lp(a) levels were not associated with clinical CAD or parental history of MI. 10 - 11 These ethnic differences in the pathogenicity of Lp(a) were unexplained.
The Lp(a) particle contains apolipoprotein (apo) (a), a highly glycosylated water-soluble protein that is linked to water-insoluble apoB-100, the principal protein moiety of low-density lipoprotein (LDL). 12 The apo(a) glycoprotein shows considerable homology with the kringle IV domain of plasminogen. The close structural relation between apo(a) and plasminogen is also reflected by the immunologic cross-reactivity between these two proteins. 13 Because of this homology, Lp(a), through its apo(a) part, competes with plasminogen for binding with fibrinogen or fibrin and thus attenuates fibrinotysis. 1413 Therefore, the apo(a) portion of Lp(a) plays a major role in the pathogenesis of CAD. It has been speculated that the types of apo(a) isoforms rather than the absolute levels of Lp(a) may be important in determining the risk of premature CAD and may par-tially explain the ethnic differences in the pathogenicity of Lp(a). The size of apo(a) isoforms has been shown to be inversely correlated with the levels of Lp(a) in whites. Such an association has not been well established in blacks. Recent genetic studies have shown that most of the variability of Lp(a) can be explained by apo(a) gene polymorphism, 16 - 17 and only certain forms of apo(a) (small) are related to high Lp(a) levels and clinical CAD. 1819 Subsequently, it has been documented that other forms (intermediate size) are also related to high Lp(a) levels, 20 and there is considerable variation in the Lp(a) levels within each category of the apo(a) isoforms. 16 ' 17 ' 20 Initially, it was suggested that these variations in the Lp(a) levels within each category of apo(a) isoform may be due to insensitive methods of measurement of apo(a) protein size. 16 However, by means of highly sensitive techniques such as pulsed-field gel electrophoresis, a similar variability in the Lp(a) levels within each DNA genotype has been observed. 1617 Although DNA genotyping appears to be the "gold standard," it is expensive. Recently it has been shown that the modified Western blot (an immunoblotting technique) was highly sensitive and identified 34 different apo(a) size isoforms. 21 ' 22 In the homozygous form only one band can be seen, and in the heterozygous forms two bands of different sizes have been identified. In the present study we used the Western blot technique of Kamboh et al 22 to identify apo(a) size variations among black and white children aged 7 to 11 years and evaluated the relation of apo(a) isoforms to Lp(a) levels and family history of premature CAD.
Methods Subjects
The subjects were 46 children aged 7 to 11 years who were randomly selected from among a sample participating in a longitudinal study of the biobehavioral antecedents of CAD. 23 They were divided according to reported family history of premature CAD. Ethnicity was determined by self-designation by parents. There were 23 children with positive family history of premature CAD (13 whites, 10 blacks) and 23 with negative family history of premature CAD (16 whites, 7 blacks). Positive family history of premature CAD was defined as occurrence of MI and/or CAD (angioplasty, coronary bypass surgery, angina on medication) among any parent, grandparent, uncle, or aunt before age 55 and was verified by contacting the appropriate physicians. Twenty-three children were designated as having positive family history of premature CAD on the basis of history of at least one of the grandparents having had CAD before age 55; the remaining two children had at least one uncle or aunt who suffered from CAD before age 55. No parents reported a history of premature CAD. All children and their parents signed informed consent forms in accordance with procedures of the Medical College of Georgia (MCG) Human Assurance Committee. In addition to demographic information such as age, sex, race, and family history of premature CAD, all children were assessed for anthropometric factors that may be related to lipids and lipoproteins. Resting systolic and diastolic blood pressures were also measured.
Measurement of Lipids, Lipoproteins, and Apolipoproteins
Children came to the MCG phlebotomy laboratory after at least 12 hours of fasting. Venous blood was collected by a pediatric phlebotomist by venipuncture into Vacutainer tubes containing EDTA. Except for apo(a) isoforms, all analyses were performed in the lipid analytic laboratory, which has been accredited by the College of American Pathologists and participates in the Centers for Disease Control and Prevention lipid standardization program. Total plasma cholesterol (TC) and triglycerides (TG) were measured with Olympus demand autoanaryzer methodology. 24 - 25 Both assays were enzymatic end points. The coefficients of variation for TC and TG were 1.23 and 2.75, respectively. High-density lipoprotein cholesterol (HDL-C) was measured on plasma supernatant after precipitation of very-low-density lipoprotein (VLDL) and LDL by dextran sulfate magnesium. 26 VLDL cholesterol (VLDL-C) was isolated from plasma by ultracentrifugation (40 000 rpm, 18 hours, 15°C) and was measured directly as d<1.006 g/mL. LDL cholesterol (LDL-C) was determined by assaying the bottom fraction (d> 1.006 g/mL). 27 We determined apoA-1 and apoB-100 (apoB) from plasma using nephelometry (Behring Diagnostic). The reproducibility coefficients for apoA-1 and apoB with a subsample (n=19) were .83 and .92, respectively.
Measurement of Lp(a)
Lp(a) was determined by an enzyme-linked immunosorbent assay (Macro Lp; Terumo Corporation Diagnostic Division) in the Clinical Nutrition Laboratory, MCG. The enzyme-linked immunosorbent assay was performed with the kit available from Terumo Medical Corporation. This kit included standards (six levels) containing Lp(a) in human plasma in buffered solution, which were used to plot a standard curve from which controls and unknowns were calculated. An external source of Lp(a) controls (two levels) assayed by Northwest Lipid Research Center in Seattle, Wash, was also included in the controls. All Lp(a) analyses were done in batches within 1 month, and all standards, controls, and plasma samples were run in duplicate. The reproducibility coefficient with a subsample (n = 19) was .93.
Measurement of Apo(a) Isoforms
Frozen plasma samples were sent to the Department of Human Genetics at the School of Public Health, University of Pittsburgh, by overnight mail in rigid polystyrene plastic boxes cooled with dry ice. The apo(a) isoforms were measured by a high-resolution sodium dodecyl sulfate-agarose gel electrophoresis method, which resolved at least 30 apo(a) isoforms. 22 - 28 We mixed 10 to 15 nL of plasma with 30 fiL of reducing buffer (1:2:10 ratio of 0-mercaptoethanol, 0.5% bromophenol blue in 5% glycerol, and 5% SDS), and the mixture was heated for 5 minutes at 100°C. Electrophoresis was performed on 1.5% agarose submarine gels (90 mmol/L tris(hydroxymethyl)aminomethane (Tris), 90 mmol/L boric acid, 2 mmol/L EDTA, 0.1% SDS) in the Hoefer submarine gel unit with LKB power supply. Electrophoresis was carried out in a tank buffer containing 45 mmol/L Tris, 45 mmol/L boric acid, 2 mmol/L EDTA, and 0.1% SDS for 7 to 8 hours at a constant 25 W at 4°C. Each gel contained a mixture of five known apo(a) isoforms as internal controls. After electrophoresis, proteins were transferred to a 0.45-/un nitrocellulose membrane by electroblotting overnight by means of a Hoefer Transphor cell at 90 V in 10 mmol/L Tris, 40 mmol/L glycine, and 5% methanol. After protein transfer, the membrane was incubated with 5% powdered skim milk for 1 hour followed by incubation overnight with rabbit anti-human apo(a) antiserum 22 and finally with goat anti-rabbit IgG conjugated with alkaline phosphatase for 3 hours. Subsequently, apo(a) bands were visualized by histochemical staining. For reliability, each sample was run twice.
Anthropometric Assessment
Body weight and height (without shoes) were measured with a Detecto scale and stadiometer. Waist and hip circumferences were taken twice and averaged. Skin folds were measured at triceps, biceps, subscapular, suprailiac, abdominal, thigh, and calf on the right side of the body with Lange calipers. Three sets of measurements were taken at each site to the nearest millimeter. The mean of the three values was used in all analyses.
Body fatness was measured with dual-energy x-ray absorptiometry (DEXA) (QDR 2000, Hologic Inc). This technique is a refinement of dual-photon absorptiometry, which has been shown to be reliable and valid for determination of percent body fat.
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Blood Pressure
Blood pressure was measured in a seated position with the right arm at heart level with a Quinton 410 blood pressure monitor after the child rested for at least 10 minutes. The accuracy of this instrument has been previously established. 31 A total of five readings of systolic and diastolic blood pressure were recorded with 1-minute intervals, and the last three were averaged to derive values for each child.
Statistical Analyses
Initial descriptive analyses for all variables were computed by race, sex, and family history of premature CAD. For variables with standardized skewness and kurtosis exceeding the range ±2, nonparametric analyses were used. The association of type of isoforms with Lp(a) levels was assessed by a Kruskal-Wallis one-way analysis by rank. The association of categorized Lp(a) levels (<25 mg/dL versus ^25 mg/dL) and apo(a) isoforms with positive family history of premature CAD was evaluated by odds ratios, 95% confidence intervals (CIs) of odds ratios, and x 2 f°r linear trend of proportions. Stratified analyses were performed to evaluate the interaction or confounding effect of race or sex in the association of categorized Lp(a) or apo(a) isoforms with family history of premature CAD. 32 Multiple linear logistic regression analyses were performed to evaluate the independent effect of apo(a) isoforms on family history of premature CAD after controlling for race, sex, Lp(a) levels, and apoB. 
Results
Descriptive statistics are provided in Table 1 . There were no significant differences between children with positive family history of premature CAD and those with negative family history of premature CAD in lipids, lipoproteins, apolipoproteins, Lp(a), blood pressure, and body fatness. The estimates of body fatness obtained through skin folds and various circumferences were similar to DEXA-measured percent body fat. Therefore, we have only used DEXA-derived percent body fat in the analyses.
As expected, Lp(a) values were not significantly correlated with lipids, lipoproteins, apolipoproteins, blood pressure, or anthropometric variables (Spearman rank correlations, all P>.Q5, data not shown). The apo(a) isoforms were classified according to the system of Kamboh et al, 22 -28 in which the apparent molecular weight ranged from 294 to 624 kD. To ensure comparability with other existing classification systems (eg, Utermann et al 33 and Gaubatz et al 34 ) , the data were reanalyzed after reclassification according to other systems. Craig et al 35 reported excellent correlations between 12 apo(a) isoforms determined by the SDSpolyacrylamide gel electrophoresis (PAGE) (Gaubatz) method and 30 apo(a) isoforms resolved by the SDSagarose (Kamboh) method. Using the Kamboh classification scheme, the present study defined isoforms 1 to 8 as large (approximate molecular weight of 531 to 624 kD), which corresponded to 10 to 12 of Gaubatz and S 5 of Utermann. Similarly, band sizes 9 to 13 of Kamboh (approximate molecular weight of 508 to 517 kD) corresponded to 7 to 8 of Gaubatz and S 4 of Utermann. Band sizes 14 to 15 of Kamboh (approximate molecular weight of 458 to 464 kD) corresponded to 6 of Gaubatz and S 3 of Utermann. Band size 16 of Kamboh (approximate molecular weight of 455 kD) corresponded to 5 of Gaubatz and S 2 of Utermann. Finally, sizes 17 to 18 of Kamboh (approximate molecular weight of 391 to 414 kD) corresponded to 2 to 3 of Gaubatz and S, of Utermann.
Where we found double-banded isoforms, the lowermolecular-weight band was considered the predominant band. Gaubatz et al 34 have shown that among heterozygote subjects, lower-molecular-weight isoforms were more intense in 51.4%, while higher-molecular-weight isoforms were more intense among only 17.5%. The remainder of the heterozygote subjects had bands of equal intensity. In our 22 heterozygote children, all lower-molecular-weight bands stained more intensely than the accompanying higher-molecular-weight bands. Nonetheless, we reanalyzed the data on heterozygotes using the higher-molecular-band allele as the predominant band. The percentages of medium isoforms in the positive and negative family history groups were 73% and 91%, respectively. The percentages of medium isoforms in the positive and negative family history groups were 27% and 9%, respectively. None of the group differences were statistically significant. Thus, regardless of whether we used the lower-or higher- molecular-weight isoforms as predominant, we did not find any significant association with family history. We grouped the isoforms into several broad groups for three reasons. First, epidemiological studies 18 ' 19 reported a significant association of Si,S 2 isofonns (low molecular weight, small size) with CAD in adults. Second, the isoforms that are not associated with CAD, if grouped together, allow one to perform meaningful statistical analysis without screening a huge population. Third, Kamboh et al 28 reported that apo(a) allele frequencies of some apo(a) alleles were significantly different in blacks and whites; the groupings in the present study were similar to those of Kamboh et al, which were required for the evaluation of racial difference in types of isoforms.
The prevalence of small apo(a) isoforms (size 16 and higher) was higher in children with positive family history of premature CAD (32%) than in children with negative family history of premature CAD (10%) (Table 1). Simple linear regression of plasma Lp(a) levels and original apo(a) phenotypes (before grouping) showed inverse correlations of Lp(a) levels and apo(a) isoform size with a significant slope (P=.OO16) and a correlation coefficient of -.49. Table 2 shows that Lp(a) levels were inversely related to apo(a) isoform size in both whites and blacks. However, marked differences in Lp(a) levels were observed between isoform sizes 1 to 8 versus others in whites and 1 to 13 versus others in blacks. In whites 24% had a large isoform, compared with only 6% of the blacks. In contrast, the mediumsized isoforms were more prevalent in blacks (75% versus 52%). For the small isoforms the black/white difference was smaller (19% versus 24%). Table 3 shows the proportion of children with positive family history of premature CAD in each group of isoforms. There was a fourfold increased risk of positive family history of premature CAD for the children with a small apo(a) isoform compared with those with a large apo(a) isoform. The odds ratios for positive family history of premature CAD associated with size of apo(a) isofonns 
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FH+ indicates positive family history of premature coronary artery disease; OR, odds ratio; MLE, maximum likelihood estimation; Cl, confidence interval.
•Reference category, tcombined groups under medium isoform size, ^combined groups under small Isoform size for trend in ORs (one-sided P=.11). not statistically significant ( Table 4 ). The odds ratios and 95% CIs of odds ratios for positive family history of premature CAD associated with high Lp(a) levels were 4.0 (0.46 to 40.34) and 1.67 (0.22 to 12.92) for girls and boys, respectively. However, Woolf s test for heterogeneity of the odds ratios was not significant (P=A9). Considerable variation in the Lp(a) levels was observed within each classified single-or double-banded category. In general, large isoforms (molecular weight of 531 to 624 kD) were associated with low Lp(a) levels, while medium-sized (molecular weight of 458 to 517 kD) and small (molecular weight of 391 to 455 kD) isoforms were associated with high Lp(a) levels (Tables  5 and 6 ). However, none of the heterozygous children (who had double bands) had two small isoform bands, whereas three of the heterozygous children had two large isoform bands (patients 1, 5, and 12), and two children had two medium-sized isoform bands (patients 7 and 16). This indicates that small isoforms are rare, and the chance that a heterozygote child will inherit small isoforms from both parents is very small. Although in the absence of family data the heterozygosity can be inferred from the presence of two distinct bands in the children, the inference of homozygosity is less tenable on the basis of observing one band only. The observation of a null allele makes it more complicated. In this sample one child had a null allele (ie, no visible bands), which was associated with a very low level of Lp(a). Table 7 shows that the size of apo(a) isofonns was significantly related to family history of premature CAD among the homozygotes (children with one band only), whereas no such association was seen in the heterozy- gotes. All four homozygotes with small apo(a) isoforms had a positive family history of premature CAD. The Lp(a) values did not correlate well with the isoform types in the homozygotes or in the heterozygotes, particularly in the children with positive family history of premature CAD. Table 8 shows linear logistic regression modeling of the risk of positive family history of premature CAD. The best model that predicted positive family history of premature CAD contained race and isoform. The regression coefficients indicate that after controlling for race, children with small isoforms had a greater than fourfold increased risk of having positive family history of premature CAD. Sex, Lp(a) levels, and apoB levels did not add significantly to the model.
Discussion
It has become increasingly clear that genetic susceptibility plays a role in the pathogenesis of coronary atherosclerosis, particularly when disease occurs at a relatively young age. One way of assessing the associations of putative genetic markers in children with CAD occurring in the distant future is to use family history of premature CAD as a surrogate measure of future CAD. 10 This study evaluated the relation of apo(a) isoforms and Lp(a) levels with positive family history of premature CAD in black and white children. As expected, Lp(a) levels were significantly higher in blacks than in whites. Both higher levels of Lp(a) and small apo(a) isoforms were associated with positive family •Logistic regression coefficient. tUkelihood statistics comparing the model containing isoform with that without it were marginally significant at P=.O65.
vealed that the associations of small apo(a) isoforms with positive family history of premature CAD were independent of race. In addition, the association of small apo(a) isoforms with family history of premature CAD was more clear in homozygotes (with one band) than in heterozygotes (one small band and another large or medium-sized band).
Although the associations of apo(a) isoforms with clinical CAD have been documented previously in adults, 1819 it was thought to add little information to that received from Lp(a) levels. However, an association of apo(a) isoforms in children with positive family history of premature CAD has not been documented previously. Given that Lp(a) levels have autosomal dominant inheritance, 33 -36 it is not surprising that small isoforms are associated with high Lp(a) levels. Although based on a small sample size, our data suggest an influence of small apo(a) isoforms on family history of premature CAD independent of race and Lp(a) levels. To our knowledge, this is the first study to show that the association of small apo(a) isoforms with positive family history of premature CAD was significant for the homozygous small isoforms but was not significant for the heterozygous small isoforms containing one small and one medium-sized or large isoform.
Several issues need to be taken into account when interpreting the results of this study. All of the previous reports associating apo(a) isoforms with clinical CAD used SDS-PAGE and immunoblotting, which isolated at least six different common isoforms. 33 ' 37 However, this technique was not sensitive enough to detect low levels of apo(a) protein and, as a result, the frequency distribution of apo(a) isoforms failed to fit the expectation of the Hardy-Weinberg equilibrium. 38 The inconsistencies in the prevalence of large isoforms in blacks and whites disappeared with further improvement of the apo(a) phenotyping. 39 - 40 Kamboh et al 22 - 28 reported a highresolution SDS-agarose gel electrophoresis method that resolved at least 30 apo(a) isoforms in whites and blacks. Our classification of large, medium, and small isoforms was similar to that of Kamboh et al, 28 who showed significant black/white differences in the frequency distributions of large and medium-sized apo(a) isoforms. We also found a similar trend that indicated a higher prevalence of medium-sized apo(a) isoforms in blacks than in whites and a higher prevalence of large apo(a) isoforms in whites than in blacks. In this study the presence of double-banded apo(a) isoforms (heterozygotes) was lower than in the previously reported studies in adults. 4142 However, these studies either did not include blacks or did not include subjects with clinical CAD or positive family history of premature CAD.
In the present study blacks had a higher levels of Lp(a) than whites. However, the inverse association of Lp(a) levels with size of apo(a) isoforms was significant only for whites. This observation further supports the ethnic differences in the distribution of apo(a) and associated Lp(a) levels. In the absence of family data, the evaluation of the effects of homozygosity and heterozygosity of the apo(a) phenotypes on levels of Lp(a) are less tenable. However, our results were congruent with previously published reports that showed higher Lp(a) levels in heterozygotes than in homozygotes. 344142 There were significant fluctuations of Lp(a) values within each isoform type, and the variation in Lp(a) levels within heterozygotes did not indicate codominant effects of the alleles, as previously suggested. 33 Our data also showed that size of apo(a) isoforms was more important than Lp(a) levels in determining risk of positive family history of premature CAD. They further showed that the homozygous small apo(a) isoforms were associated with positive family history of premature CAD. The proportions of single-and double-band isoforms in our study were 48% and 50%, respectively, and the remainder (2%) was null alleles. However, the proportions of single-and double-banded isoforms were similar in children with positive family history of premature CAD and negative family history of premature CAD.
In conclusion, size of apo(a) isoforms, particularly homozygous small (^16) isoforms, was a major determinant of positive family history of premature CAD independent of race. The apo(a) genetic polymorphism clearly influences Lp(a) levels in both blacks and whites. However, the distributions of types of isoforms are different. Further studies should be undertaken with a large sample of parents with premature CAD and their children to evaluate the influence of homozygous small apo(a) isoforms in the pathogenesis of premature CAD.
